BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Wang J, Ren T, Huang Y, Liang X, Yu Y, Wang W, Niu J, Guo W. Bone marrow mesenchymal stem cell-derived exosomal miR-206 inhibits osteosarcoma progression by targeting TRA2B. Cancer Lett 2020;490:54-65. [PMID: 32682951 DOI: 10.1016/j.canlet.2020.07.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Lu Y, Cao G, Lan H, Liao H, Hu Y, Feng H, Liu X, Huang P. Chondrocyte-derived Exosomal miR-195 Inhibits Osteosarcoma Cell Proliferation and Anti-Apoptotic by Targeting KIF4A in vitro and in vivo. Transl Oncol 2021;16:101289. [PMID: 34952333 DOI: 10.1016/j.tranon.2021.101289] [Reference Citation Analysis]
2 Chang X, Ma Z, Zhu G, Lu Y, Yang J. New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma. J Bone Oncol 2021;29:100372. [PMID: 34258182 DOI: 10.1016/j.jbo.2021.100372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yan T, Wu M, Lv S, Hu Q, Xu W, Zeng A, Huang K, Zhu X. Exosomes derived from microRNA-512-5p-transfected bone mesenchymal stem cells inhibit glioblastoma progression by targeting JAG1. Aging (Albany NY) 2021;13:9911-26. [PMID: 33795521 DOI: 10.18632/aging.202747] [Reference Citation Analysis]
4 Bei HP, Hung PM, Yeung HL, Wang S, Zhao X. Bone-a-Petite: Engineering Exosomes towards Bone, Osteochondral, and Cartilage Repair. Small 2021;:e2101741. [PMID: 34288410 DOI: 10.1002/smll.202101741] [Reference Citation Analysis]
5 Hu Y, Liang D, Chen X, Chen L, Bai J, Li H, Yin C, Zhong W. [MiR-671-5p negatively regulates SMAD3 to inhibit migration and invasion of osteosarcoma cells]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:1562-8. [PMID: 34755673 DOI: 10.12122/j.issn.1673-4254.2021.10.16] [Reference Citation Analysis]
6 Zhang H, Wang J, Ren T, Huang Y, Yu Y, Chen C, Huang Q, Guo W. LncRNA CASC15 is Upregulated in Osteosarcoma Plasma Exosomes and CASC15 Knockdown Inhibits Osteosarcoma Progression by Regulating miR-338-3p/RAB14 Axis. Onco Targets Ther 2020;13:12055-66. [PMID: 33262606 DOI: 10.2147/OTT.S282053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Li S, Wang X. The potential roles of exosomal noncoding RNAs in osteosarcoma. J Cell Physiol 2021;236:3354-65. [PMID: 33044018 DOI: 10.1002/jcp.30101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chen C, Zhang H, Yu Y, Huang Q, Wang W, Niu J, Lou J, Ren T, Huang Y, Guo W. Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3. Aging (Albany NY) 2021;13:17901-13. [PMID: 34170850 DOI: 10.18632/aging.203196] [Reference Citation Analysis]
9 Yassine S, Alaaeddine N. Mesenchymal Stem Cell Exosomes and Cancer: Controversies and Prospects. Adv Biol (Weinh) 2021;:e2101050. [PMID: 34939371 DOI: 10.1002/adbi.202101050] [Reference Citation Analysis]
10 Huang Q, Liang X, Ren T, Huang Y, Zhang H, Yu Y, Chen C, Wang W, Niu J, Lou J, Guo W. The role of tumor-associated macrophages in osteosarcoma progression - therapeutic implications. Cell Oncol (Dordr) 2021;44:525-39. [PMID: 33788151 DOI: 10.1007/s13402-021-00598-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang S, Zhang H, Li B, Chen C, Ren T, Huang Y, Liu K, Li J, Guo W. Knockdown of a specific circular non-coding RNA significantly suppresses osteosarcoma progression. Engineering 2022. [DOI: 10.1016/j.eng.2021.12.007] [Reference Citation Analysis]
12 Pi YN, Xia BR, Jin MZ, Jin WL, Lou G. Exosomes: Powerful weapon for cancer nano-immunoengineering. Biochem Pharmacol 2021;186:114487. [PMID: 33647264 DOI: 10.1016/j.bcp.2021.114487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Weng Z, Zhang B, Wu C, Yu F, Han B, Li B, Li L. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol 2021;14:136. [PMID: 34479611 DOI: 10.1186/s13045-021-01141-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Shi Z, Wang K, Xing Y, Yang X. CircNRIP1 Encapsulated by Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicles Aggravates Osteosarcoma by Modulating the miR-532-3p/AKT3/PI3K/AKT Axis. Front Oncol 2021;11:658139. [PMID: 34660257 DOI: 10.3389/fonc.2021.658139] [Reference Citation Analysis]
15 Huang Y, Zhang X, Zhan J, Yan Z, Chen D, Xue X, Pan X. Bone marrow mesenchymal stem cell-derived exosomal miR-206 promotes osteoblast proliferation and differentiation in osteoarthritis by reducing Elf3. J Cell Mol Med 2021;25:7734-45. [PMID: 34160894 DOI: 10.1111/jcmm.16654] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Zhang H, Yu Y, Wang J, Han Y, Ren T, Huang Y, Chen C, Huang Q, Wang W, Niu J, Lou J, Guo W. Macrophages-derived exosomal lncRNA LIFR-AS1 promotes osteosarcoma cell progression via miR-29a/NFIA axis. Cancer Cell Int 2021;21:192. [PMID: 33794884 DOI: 10.1186/s12935-021-01893-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhang X, Zhou Y, Ye Y, Wu R, Li W, Yao C, Wang S. Human umbilical cord mesenchymal stem cell-derived exosomal microRNA-148a-3p inhibits neointimal hyperplasia by targeting Serpine1. Arch Biochem Biophys 2022;:109155. [PMID: 35218720 DOI: 10.1016/j.abb.2022.109155] [Reference Citation Analysis]
18 Huang Y, Li Z, Lin E, He P, Ru G. Oxidative damage-induced hyperactive ribosome biogenesis participates in tumorigenesis of offspring by cross-interacting with the Wnt and TGF-β1 pathways in IVF embryos. Exp Mol Med 2021;53:1792-806. [PMID: 34848840 DOI: 10.1038/s12276-021-00700-0] [Reference Citation Analysis]
19 Hu Y, Zai H, Jiang W, Yao Y, Ou Z, Zhu Q. miR-126 in Extracellular Vesicles Derived from Hepatoblastoma Cells Promotes the Tumorigenesis of Hepatoblastoma through Inducing the Differentiation of BMSCs into Cancer Stem Cells. J Immunol Res 2021;2021:6744715. [PMID: 34746322 DOI: 10.1155/2021/6744715] [Reference Citation Analysis]
20 Yang L, Huang X, Guo H, Wang L, Yang W, Wu W, Jing D, Shao Z. Exosomes as Efficient Nanocarriers in Osteosarcoma: Biological Functions and Potential Clinical Applications. Front Cell Dev Biol 2021;9:737314. [PMID: 34712664 DOI: 10.3389/fcell.2021.737314] [Reference Citation Analysis]
21 Li S, Liu F, Zheng K, Wang W, Qiu E, Pei Y, Wang S, Zhang J, Zhang X. CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis. Mol Cancer 2021;20:161. [PMID: 34876132 DOI: 10.1186/s12943-021-01453-0] [Reference Citation Analysis]
22 Sarhadi VK, Daddali R, Seppänen-Kaijansinkko R. Mesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy. Int J Mol Sci 2021;22:11035. [PMID: 34681692 DOI: 10.3390/ijms222011035] [Reference Citation Analysis]
23 Zhang S, Chen H, Liu W, Fang L, Qian Z, Kong R, Zhang Q, Li J, Cao X. miR-766-3p Targeting BCL9L Suppressed Tumorigenesis, Epithelial-Mesenchymal Transition, and Metastasis Through the β-Catenin Signaling Pathway in Osteosarcoma Cells. Front Cell Dev Biol 2020;8:594135. [PMID: 33117820 DOI: 10.3389/fcell.2020.594135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Liu T, Li T, Zheng Y, Xu X, Sun R, Zhan S, Guo X, Zhao Z, Zhu W, Feng B, Wei F, Jiang N, Wang J, Chen X, Fang F, Guo H, Yang R. Evaluating adipose-derived stem cell exosomes as miRNA drug delivery systems for the treatment of bladder cancer. Cancer Med 2022. [PMID: 35441482 DOI: 10.1002/cam4.4745] [Reference Citation Analysis]
25 Xu C, Wang M, Zandieh-Doulabi B, Sun W, Wei L, Liu Y. To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein's Role in Osteosarcomagenesis. Front Cell Dev Biol 2021;9:740783. [PMID: 34869325 DOI: 10.3389/fcell.2021.740783] [Reference Citation Analysis]
26 Li S. The basic characteristics of extracellular vesicles and their potential application in bone sarcomas. J Nanobiotechnology 2021;19:277. [PMID: 34535153 DOI: 10.1186/s12951-021-01028-7] [Reference Citation Analysis]
27 Wu C, Li Z, Feng G, Wang L, Xie J, Jin Y, Wang L, Liu S. Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway. Bioengineered 2021;12:8378-95. [PMID: 34592889 DOI: 10.1080/21655979.2021.1987092] [Reference Citation Analysis]
28 Reale A, Khong T, Mithraprabhu S, Spencer A. Translational Potential of RNA Derived From Extracellular Vesicles in Multiple Myeloma. Front Oncol 2021;11:718502. [PMID: 34513695 DOI: 10.3389/fonc.2021.718502] [Reference Citation Analysis]
29 Tominaga N. Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles. Cancers (Basel) 2021;13:6303. [PMID: 34944923 DOI: 10.3390/cancers13246303] [Reference Citation Analysis]
30 Zhou P, Xu P, Yu W, Li H. MiR-206 improves intervertebral disk degeneration by targeting GJA1. J Orthop Surg Res 2022;17. [DOI: 10.1186/s13018-022-03044-1] [Reference Citation Analysis]
31 Liu W, Wang B, Duan A, Shen K, Zhang Q, Tang X, Wei Y, Tang J, Zhang S. Exosomal transfer of miR-769-5p promotes osteosarcoma proliferation and metastasis by targeting DUSP16. Cancer Cell Int 2021;21:541. [PMID: 34663350 DOI: 10.1186/s12935-021-02257-4] [Reference Citation Analysis]
32 Chen L, Wang L, Zhu L, Xu Z, Liu Y, Li Z, Zhou J, Luo F. Exosomes as Drug Carriers in Anti-Cancer Therapy. Front Cell Dev Biol 2022;10:728616. [DOI: 10.3389/fcell.2022.728616] [Reference Citation Analysis]